Azacytidine and decitabine might be promising therapeutic strategies for translocated MYC, found not only in Burkitt’s lymphoma, but also in some diffuse large B-cell lymphoma (DLBCL) and other types of non-Hodgkin lymphoma [153,154]. Here, MYC is linked to Burkitt lymphoma.